BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He J, Xu S, Mixson AJ. The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges. Pharmaceutics 2020;12:E774. [PMID: 32823960 DOI: 10.3390/pharmaceutics12080774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu S, He J, Imtiyaz Z, Agrawal AK, Woodle MC, Mixson AJ. Marked increase in tumor transfection with a truncated branched polymer. J Gene Med 2021;:e3396. [PMID: 34713552 DOI: 10.1002/jgm.3396] [Reference Citation Analysis]
2 Shueng P, Yu L, Hou H, Chiu H, Lo C. Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug Delivery. IJMS 2022;23:3080. [DOI: 10.3390/ijms23063080] [Reference Citation Analysis]
3 Zhang Y, Li C, Wu X, Deng F, Huang F, Zhang Y, Liu J, Gui H, Ma R, Shi L. Nanochaperones tailored for insulin delivery to reduce immune clearance and enhance bioavailability of insulin. Chemical Engineering Journal 2022;435:134866. [DOI: 10.1016/j.cej.2022.134866] [Reference Citation Analysis]
4 Wahane A, Malik S, Shih KC, Gaddam RR, Chen C, Liu Y, Nieh MP, Vikram A, Bahal R. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy. ACS Appl Mater Interfaces 2021;13:45244-58. [PMID: 34524806 DOI: 10.1021/acsami.1c11981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Krhač Levačić A, Berger S, Müller J, Wegner A, Lächelt U, Dohmen C, Rudolph C, Wagner E. Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer. J Control Release 2021;339:27-40. [PMID: 34547258 DOI: 10.1016/j.jconrel.2021.09.016] [Reference Citation Analysis]
6 Rhym LH, Anderson DG. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art. Med 2022;3:167-87. [DOI: 10.1016/j.medj.2022.02.001] [Reference Citation Analysis]
7 Huang R, Gyanani V, Zhao S, Lu Y, Guo X. Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery. Pharmaceuticals 2022;15:306. [DOI: 10.3390/ph15030306] [Reference Citation Analysis]
8 Brodyagin N, Kataoka Y, Kumpina I, McGee DW, Rozners E. Cellular uptake of 2-aminopyridine-modified peptide nucleic acids conjugated with cell-penetrating peptides. Biopolymers 2021;:e23484. [PMID: 34914092 DOI: 10.1002/bip.23484] [Reference Citation Analysis]
9 Berger S, Krhač Levačić A, Hörterer E, Wilk U, Benli-Hoppe T, Wang Y, Öztürk Ö, Luo J, Wagner E. Optimizing pDNA Lipo-polyplexes: A Balancing Act between Stability and Cargo Release. Biomacromolecules 2021;22:1282-96. [PMID: 33616407 DOI: 10.1021/acs.biomac.0c01779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gosangi M, Ravula V, Rapaka H, Patri SV. α-Tocopherol-anchored gemini lipids with delocalizable cationic head groups: the effect of spacer length on DNA compaction and transfection properties. Org Biomol Chem 2021;19:4565-76. [PMID: 33954315 DOI: 10.1039/d1ob00475a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 He J, Xu S, Leng Q, Mixson AJ. Location of a single histidine within peptide carriers increases mRNA delivery. J Gene Med 2021;23:e3295. [PMID: 33171540 DOI: 10.1002/jgm.3295] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Váňová J, Číhařová B, Hejtmánková A, Epperla CP, Škvára P, Forstová J, Hubálek Kalbáčová M, Španielová H. VirPorters: Insights into the action of cationic and histidine-rich cell-penetrating peptides. Int J Pharm 2021;611:121308. [PMID: 34800617 DOI: 10.1016/j.ijpharm.2021.121308] [Reference Citation Analysis]